Table 1.
Patients and treatment arms
Age groups, years | 16–29 | 30–44 | 45–59 | At least 60 |
---|---|---|---|---|
All patients, n | 120 | 383 | 495 | 526 |
Imatinib (400 mg), n (%) | 25 (21) | 93 (24) | 131 (26) | 147 (28) |
Imatinib (400 mg + IFN-α), n (%) | 39 (32) | 102 (27) | 139 (28) | 145 (27) |
Imatinib (400 mg + cytarabine), n (%) | 13 (11) | 39 (10) | 53 (11) | 53 (10) |
Imatinib (400 mg after IFN-α failure), n (%) | 8 (7) | 35 (9) | 37 (7) | 48 (9) |
Imatinib (800 mg), n (%) | 35 (29) | 114 (29) | 135 (27) | 133 (25) |
N number of patients, IFN-α interferon